Strathmann wins cancer contract
German contract manufacturer Strathmann Biotec has won a contract to manufacture clinical supplies a new type of cancer treatment in development at Sweden's Active Biotech.
Archives for June 2, 2004
Solutia plans leading role in drug conjugates
The Pharmaceutical Services Division (PSD) of US chemicals firm Solutia is planning a charge into the market for supplying drug conjugates, which are becoming more and more common in the treatment of diseases such as cancer.
Cattle antibody production moves a step closer
Researchers have taken a step forward in the development of a system for making unlimited quantities of antibody-based drugs for human applications in cattle.
Eiffel to accelerate drug re-engineering efforts
Drug re-engineering company Eiffel Technologies will add to its existing project in improving insulin delivery with the start of clinical trials of an in-house product early next year, writes Wai Lang Chu.